Community Health Systems, Inc (NYSE: CYH): To Buy Or Not To Buy, That Is The Question

Community Health Systems, Inc (CYH) concluded trading on Wednesday at a closing price of $3.43, with 2.76 million shares of worth about $9.46 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.14% during that period and on December 04, 2024 the price saw a gain of about 0.88%. Currently the company’s common shares owned by public are about 138.94M shares, out of which, 118.97M shares are available for trading.

Stock saw a price change of -3.92% in past 5 days and over the past one month there was a price change of -21.69%. Year-to-date (YTD), CYH shares are showing a performance of 9.58% which increased to 30.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.31 but also hit the highest price of $6.29 during that period. The average intraday trading volume for Community Health Systems, Inc shares is 1.72 million. The stock is currently trading -10.98% below its 20-day simple moving average (SMA20), while that difference is down -26.79% for SMA50 and it goes to -15.97% lower than SMA200.

Community Health Systems, Inc (NYSE: CYH) currently have 138.94M outstanding shares and institutions hold larger chunk of about 73.41% of that.

The stock has a current market capitalization of $476.59M and its 3Y-monthly beta is at 1.57. It has posted earnings per share of -$3.02 in the same period. It has Quick Ratio of 1.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CYH, volatility over the week remained 4.76% while standing at 5.96% over the month.

Stock’s fiscal year EPS is expected to rise by 62.31% while it is estimated to increase by 140.33% in next year. EPS is likely to shrink at an annualized rate of -7.95% for next 5-years, compared to annual growth of 31.96% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on November 25, 2024 offering an Underweight rating for the stock and assigned a target price range of between $5 and $2.50 to it. On March 06, 2024, Barclays Initiated their recommendations, while on June 17, 2022, Loop Capital Initiated their ratings for the stock with a price target of $5. Stock get a Neutral rating from BofA Securities on June 15, 2022.

Most Popular

Related Posts